跳至主要内容
临床试验/NCT02686853
NCT02686853Unknown4 期

Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis Without Acquired Immune Deficiency Syndrome

Hui Bu0 个研究点目标入组 40 人开始时间: 2016年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
40
主要终点
laboratory examination of cerebrospinal fluid

研究概览

简要总结

The main purpose of this study is to observe the clinical effect of intrathecal administration of liposomal amphotericin B in Cryptococcal Meningitis without Acquired Immune Deficiency Syndrome (AIDS).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cryptococcus neoformans are found in CSF

排除标准

  • Patients with serious heart, lung, liver and renal insufficiency.
  • Patients who took broad-spectrum antibiotics and corticosteroids for a long-term.
  • Patients with AIDS or obvious immunodeficiency.
  • Patients with long term dialysis or intravenous catheter.
  • Patients with other brain organic disease such as purulent meningitis, intracranial swelling, etc.

研究组 & 干预措施

Intrathecal administration group

Experimental

干预措施: Liposomal amphotericin B (Drug)

结局指标

主要结局

laboratory examination of cerebrospinal fluid

时间窗: 2 to 4 weeks

It includes routine test,biochemistry indicators and cytology ,namely white blood cell count per litre, protein(in g/l),glucose(in mmol/l)and chloride(in mmol/l)in cerebrospinal fluid ,an assessment will be assessed every week

次要结局

  • changes of clinical symptoms(2 to 4 weeks)

研究者

发起方
Hui Bu
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hui Bu

Study Principal Investigator

Hebei Medical University

相似试验

Efficacy of Intrathecal Administration of Liposomal... | 临床试验